Toward Rational Design of Orally Bioavailable PROTACs: Development of a Fully Computational Oral Absorption Score

IF 3.9 3区 医学 Q2 CHEMISTRY, MEDICINAL ACS Medicinal Chemistry Letters Pub Date : 2026-10-08 Epub Date: 2026-09-17 DOI:10.1021/acsmedchemlett.6c00305
Arman Fathizadeh, Erika M. V. Araujo, Nicholas T. Cockroft, Brett R. Beno, Keith R. Hornberger
{"title":"Toward Rational Design of Orally Bioavailable PROTACs: Development of a Fully Computational Oral Absorption Score","authors":"Arman Fathizadeh,&nbsp;Erika M. V. Araujo,&nbsp;Nicholas T. Cockroft,&nbsp;Brett R. Beno,&nbsp;Keith R. Hornberger","doi":"10.1021/acsmedchemlett.6c00305","DOIUrl":null,"url":null,"abstract":"<p>Achieving adequate oral absorption for proteolysis-targeting\r\nchimeras\r\n(PROTACs) remains challenging due to their size, polarity, and conformational\r\ncomplexity. While existing approaches often rely on physicochemical\r\nproperty space or chameleonicity-driven models, a generalizable framework\r\nfor guiding compound design prior to synthesis is lacking. Here, we\r\nintroduce comPASS, a fully computational scoring function derived\r\nfrom molecular dynamics-based descriptors that is designed to capture\r\nthe balance between molecular extension and exposed polarity through\r\nnormalized radius of gyration and three-dimensional polar surface\r\narea of PROTACs. Across mouse and rat data sets, comPASS shows consistent\r\npredictive performance and may facilitate prioritization of compounds\r\nat early design stages. We further show that within the data sets\r\nstudied, extended molecular geometries are associated with improved\r\nabsorption, when increased elongation is not driven solely by increases\r\nin molecular size. To assess the potential benefit of incorporating\r\nexperimental information, we also developed an enhanced variant, ePASS,\r\nwhich incorporates experimental polar surface area (EPSA) and lipophilicity\r\nterms consistent with prior approaches and shows promising predictive\r\nperformance relative to similar literature methods. Together, these\r\nresults establish practical guidance for presynthetic prioritization\r\nof PROTACs and provide a potential framework for guiding the design\r\nof orally absorbed PROTACs.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"17 10","pages":"2168–2174"},"PeriodicalIF":3.9000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsmedchemlett.6c00305","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Achieving adequate oral absorption for proteolysis-targeting chimeras (PROTACs) remains challenging due to their size, polarity, and conformational complexity. While existing approaches often rely on physicochemical property space or chameleonicity-driven models, a generalizable framework for guiding compound design prior to synthesis is lacking. Here, we introduce comPASS, a fully computational scoring function derived from molecular dynamics-based descriptors that is designed to capture the balance between molecular extension and exposed polarity through normalized radius of gyration and three-dimensional polar surface area of PROTACs. Across mouse and rat data sets, comPASS shows consistent predictive performance and may facilitate prioritization of compounds at early design stages. We further show that within the data sets studied, extended molecular geometries are associated with improved absorption, when increased elongation is not driven solely by increases in molecular size. To assess the potential benefit of incorporating experimental information, we also developed an enhanced variant, ePASS, which incorporates experimental polar surface area (EPSA) and lipophilicity terms consistent with prior approaches and shows promising predictive performance relative to similar literature methods. Together, these results establish practical guidance for presynthetic prioritization of PROTACs and provide a potential framework for guiding the design of orally absorbed PROTACs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
面向口服生物利用度PROTACs的合理设计:一个完全计算的口服吸收评分的发展
由于蛋白水解靶向嵌合体(PROTACs)的大小、极性和构象复杂性,实现足够的口服吸收仍然具有挑战性。虽然现有的方法通常依赖于物理化学性质空间或变色体驱动的模型,但缺乏一个在合成之前指导化合物设计的可推广的框架。在这里,我们介绍了comPASS,这是一个基于分子动力学描述符的完全计算评分函数,旨在通过归一化的旋转半径和PROTACs的三维极性表面积来捕获分子扩展和暴露极性之间的平衡。在小鼠和大鼠数据集中,comPASS显示出一致的预测性能,并可能有助于在早期设计阶段对化合物进行优先排序。我们进一步表明,在研究的数据集中,延伸的分子几何形状与吸收的改善有关,当延伸率的增加不仅仅是由分子大小的增加所驱动的。为了评估纳入实验信息的潜在益处,我们还开发了一种增强的变体ePASS,它包含了与先前方法一致的实验极性表面积(EPSA)和亲脂性术语,并且相对于类似的文献方法显示出有希望的预测性能。总之,这些结果为protac的预合成优先排序提供了实用指导,并为指导口服吸收protac的设计提供了潜在的框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters CHEMISTRY, MEDICINAL-
CiteScore
7.30
自引率
2.40%
发文量
328
审稿时长
1 months
期刊介绍: ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to: Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics) Biological characterization of new molecular entities in the context of drug discovery Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc. Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic Mechanistic drug metabolism and regulation of metabolic enzyme gene expression Chemistry patents relevant to the medicinal chemistry field.
期刊最新文献
Issue Editorial Masthead Issue Publication Information Design, Synthesis, and Antimicrobial Activity of Novel Cyt-bd Inhibitors Targeting Energy Compensation in Mycobacterium tuberculosis Fluorinated 4-Methylideneisoxazolidin-5-ones: Synthesis and Apoptosis-Inducing Antiproliferative Activity The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV-2 Proteins
wanfang
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1